معرفی
Ruixue Ai is a Postdoctoral Fellow at the Department of Clinical Molecular Biology within the Faculty of Medicine at the University of Oslo, with operational ties to Akershus University Hospital in Lørenskog. Her research bridges clinical molecular biology and translational neuroscience, focusing on neurodegenerative mechanisms and therapeutic innovation.
Her primary research interests include molecular pathways in Alzheimer's and Parkinson's diseases, with emphasis on amyloid-beta/tau pathology, mitophagy dysregulation, and biomarker identification. She integrates artificial intelligence for drug discovery and diagnostic modeling, extending into psychoneuroimmunology aspects of conditions like burning mouth syndrome and delirium. This interdisciplinary approach combines wet-lab molecular techniques with computational analysis to address neurodegeneration from multiple angles.
Analysis of her publication trends reveals consistent focus on AI-enhanced therapeutic development for neurodegenerative disorders, particularly through cross-species validation (e.g., C. elegans models) and multi-omics biomarker discovery. Recent work demonstrates growing emphasis on machine learning for target identification and the mechanistic links between aging, DNA repair, and cognitive decline, reflecting an evolving trajectory toward computationally driven precision medicine in neurology.
